SCHLX vs. RYOIX

Last updated Jun 6, 2026

SCHLX (DWS Health and Wellness Fund) and RYOIX (Rydex Biotechnology Fund) are both Health & Biotech Equities funds. Over the past 10 years, SCHLX returned 7.47%/yr vs 8.75%/yr for RYOIX. Their correlation of 0.85 suggests significant overlap in exposure. SCHLX charges 0.84%/yr vs 1.36%/yr for RYOIX.

Performance

SCHLX vs. RYOIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in DWS Health and Wellness Fund (SCHLX) and Rydex Biotechnology Fund (RYOIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SCHLX achieves a -4.95% return, which is significantly lower than RYOIX's 7.71% return. Over the past 10 years, SCHLX has underperformed RYOIX with an annualized return of 7.47%, while RYOIX has yielded a comparatively higher 8.75% annualized return.

SCHLX

• 1D: 3.12%
• 1M: 3.30%
• YTD: -4.95%
• 6M: -4.34%
• 1Y: 10.41%
• 3Y*: 5.55%
• 5Y*: 4.27%
• 10Y*: 7.47%

RYOIX

• 1D: 2.44%
• 1M: 1.13%
• YTD: 7.71%
• 6M: 6.36%
• 1Y: 43.56%
• 3Y*: 14.28%
• 5Y*: 5.61%
• 10Y*: 8.75%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SCHLX vs. RYOIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SCHLX DWS Health and Wellness Fund	-4.95%	12.67%	3.62%	5.56%	-7.22%	15.43%	15.40%	22.40%	3.50%	19.37%
RYOIX Rydex Biotechnology Fund	7.71%	30.62%	-0.95%	6.06%	-13.04%	2.05%	21.94%	30.69%	-8.94%	29.68%

Correlation

The correlation between SCHLX and RYOIX is 0.74, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.74
Correlation (3Y) Calculated over the trailing 3-year period	0.72
Correlation (5Y) Calculated over the trailing 5-year period	0.75
Correlation (10Y) Calculated over the trailing 10-year period	0.81
Correlation (All Time) Calculated using the full available price history since Jan 5, 1999	0.85

The correlation between SCHLX and RYOIX shifts across timeframes, from 0.72 (3 years) to 0.85 (all time), reflecting how their relationship changes across market environments.

Return for Risk

SCHLX vs. RYOIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SCHLX

SCHLX Risk / Return Rank: 9
SCHLX Sharpe Ratio Rank: 9
SCHLX Sortino Ratio Rank: 10
SCHLX Omega Ratio Rank: 9
SCHLX Calmar Ratio Rank: 9
SCHLX Martin Ratio Rank: 7

RYOIX

RYOIX Risk / Return Rank: 72
RYOIX Sharpe Ratio Rank: 61
RYOIX Sortino Ratio Rank: 62
RYOIX Omega Ratio Rank: 50
RYOIX Calmar Ratio Rank: 93
RYOIX Martin Ratio Rank: 92

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SCHLX vs. RYOIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for DWS Health and Wellness Fund (SCHLX) and Rydex Biotechnology Fund (RYOIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SCHLX	RYOIX	Difference
Sharpe ratio: Return per unit of total volatility	0.70	2.24	-1.53
Sortino ratio: Return per unit of downside risk	1.15	3.21	-2.05
Omega ratio: Gain probability vs. loss probability	1.13	1.37	-0.24
Calmar ratio: Return relative to maximum drawdown	0.80	5.18	-4.37
Martin ratio: Return relative to average drawdown	1.91	18.57	-16.66
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SCHLX vs. RYOIX - Sharpe Ratio Comparison

The current SCHLX Sharpe Ratio is 0.70, which is lower than the RYOIX Sharpe Ratio of 2.24. The chart below compares the historical Sharpe Ratios of SCHLX and RYOIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	SCHLX	RYOIX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.70	2.24	-1.53
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.29	0.27	+0.02
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.45	0.38	+0.07
Sharpe Ratio (All Time) Calculated using the full available price history	0.50	0.36	+0.14

Drawdowns

SCHLX vs. RYOIX - Drawdown Comparison

The maximum SCHLX drawdown since its inception was -45.46%, smaller than the maximum RYOIX drawdown of -74.43%. Use the drawdown chart below to compare losses from any high point for SCHLX and RYOIX.

Drawdown Indicators

	SCHLX	RYOIX	Difference
Max Drawdown Largest peak-to-trough decline	-45.46%	-74.43%	+28.97%
Max Drawdown (1Y) Largest decline over 1 year	-13.08%	-8.43%	-4.65%
Max Drawdown (3Y) Largest decline over 3 years	-17.73%	-23.47%	+5.74%
Max Drawdown (5Y) Largest decline over 5 years	-18.62%	-33.66%	+15.04%
Max Drawdown (10Y) Largest decline over 10 years	-27.47%	-33.66%	+6.19%
Current Drawdown Current decline from peak	-8.21%	-0.19%	-8.02%
Average Drawdown Average peak-to-trough decline	-9.17%	-27.63%	+18.46%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.48%	2.35%	+3.13%

Volatility

SCHLX vs. RYOIX - Volatility Comparison

The current volatility for DWS Health and Wellness Fund (SCHLX) is 5.14%, while Rydex Biotechnology Fund (RYOIX) has a volatility of 7.02%. This indicates that SCHLX experiences smaller price fluctuations and is considered to be less risky than RYOIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SCHLX	RYOIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.14%	7.02%	-1.88%
Volatility (6M) Calculated over the trailing 6-month period	10.68%	14.99%	-4.31%
Volatility (1Y) Calculated over the trailing 1-year period	14.94%	19.51%	-4.57%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.84%	21.25%	-6.41%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.70%	23.24%	-6.54%

SCHLX vs. RYOIX - Expense Ratio Comparison

SCHLX has a 0.84% expense ratio, which is lower than RYOIX's 1.36% expense ratio.

Dividends

SCHLX vs. RYOIX - Dividend Comparison

SCHLX's dividend yield for the trailing twelve months is around 5.48%, less than RYOIX's 11.67% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
RYOIX Rydex Biotechnology Fund	11.67%	12.57%	14.61%	0.00%	1.29%	19.39%	7.28%	8.58%	14.11%	5.38%	0.00%	1.45%
SCHLX DWS Health and Wellness Fund	5.48%	5.21%	1.19%	5.29%	1.77%	9.02%	9.13%	9.88%	11.48%	6.52%	2.84%	16.39%

Frequently Asked Questions

Can I hold both SCHLX and RYOIX in my portfolio?

SCHLX and RYOIX have a correlation of 0.74, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SCHLX or RYOIX?

RYOIX has higher volatility (7.02%) compared to SCHLX (5.14%). In terms of maximum drawdown, SCHLX dropped -45.46% vs RYOIX's -74.43%.

Which has better risk-adjusted returns?

RYOIX currently has the higher Sharpe Ratio (2.24 vs 0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.